Literature DB >> 18475486

Study on the pathogenesis of pathophysiological changes of burn systemic infection.

L Ao Ngao1, H Yuesheng, Y Zongcheng.   

Abstract

The present prospective study showed that incidence of systemic infection in severe burn patients was 30.9%. Toxic shock and multiple organ failure (MOF) developed in all patients with uncontrolled systemic infection. Both morbidity and mortality of MOF were 76.5%. In the infection group, plasma TXB(2) and TXB(2)/6-keto-PGF(1alpha) ratio increased markedly. Their changes were closely correlated with the clinical course and deterioration of systemic infection. Circulatory platelet aggregate ratio decreased significantly, while myocardiac enzyme spectrum greatly increased. Thrombi were observed in visceral tissues from patients dying of systemic infection. These suggested that TXA(2)/PGI(2). imbalance promoting microaggregate and thrombus formation may be one of the pathogenic effects of toxic shock and MOF in burn patients.

Entities:  

Year:  1992        PMID: 18475486      PMCID: PMC2365372          DOI: 10.1155/S0962935192000553

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  11 in total

1.  A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency.

Authors:  K K Wu; J C Hoak
Journal:  Lancet       Date:  1974-10-19       Impact factor: 79.321

Review 2.  The prostacyclin--thromboxane A2 balance: pathophysiological and therapeutic implications.

Authors:  S Bunting; S Moncada; J R Vane
Journal:  Br Med Bull       Date:  1983-07       Impact factor: 4.291

3.  Clinical studies on postburn multiple organ failure: its aetiological factors and monitoring.

Authors:  Y S Huang; A Li; Z C Yang
Journal:  Burns       Date:  1992-02       Impact factor: 2.744

4.  A prospective clinical study on the pathogenesis of multiple organ failure in severely burned patients.

Authors:  Y S Huang; A o Li; Z C Yang
Journal:  Burns       Date:  1992-02       Impact factor: 2.744

5.  Roles of thromboxane and its inhibitor anisodamine in burn shock.

Authors:  Y S Huang; A Li; Z C Yang
Journal:  Burns       Date:  1990-08       Impact factor: 2.744

6.  Plasma thromboxane concentrations are raised in patients dying with septic shock.

Authors:  H D Reines; P V Halushka; J A Cook; W C Wise; W Rambo
Journal:  Lancet       Date:  1982-07-24       Impact factor: 79.321

7.  Prostacyclin reversal of lethal endotoxemia in dogs.

Authors:  M M Krausz; T Utsunomiya; G Feuerstein; J H Wolfe; D Shepro; H B Hechtman
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

8.  Leukocytes, platelets, and thromboxane A2 in endotoxin-induced lung injury.

Authors:  M E Smith; R Gunther; M Gee; J Flynn; R H Demling
Journal:  Surgery       Date:  1981-07       Impact factor: 3.982

9.  Role of thromboxane and prostacyclin in pulmonary vasomotor changes after endotoxin in dogs.

Authors:  C A Hales; L Sonne; M Peterson; D Kong; M Miller; W D Watkins
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

10.  Protective effects of thromboxane synthetase inhibitors in rats in endotoxic shock.

Authors:  W C Wise; J A Cook; P V Halushka; D R Knapp
Journal:  Circ Res       Date:  1980-06       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.